AZN logo

AstraZeneca PLC (AZN) Cash from operations

annual CFO:

$11.86B+$1.52B(+14.65%)
December 31, 2024

Summary

  • As of today (August 21, 2025), AZN annual cash flow from operations is $11.86 billion, with the most recent change of +$1.52 billion (+14.65%) on December 31, 2024.
  • During the last 3 years, AZN annual CFO has risen by +$5.90 billion (+98.91%).
  • AZN annual CFO is now at all-time high.

Performance

AZN Cash from operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAZNcash flow metrics

quarterly CFO:

$3.51B-$270.88M(-7.17%)
June 30, 2025

Summary

  • As of today (August 21, 2025), AZN quarterly cash flow from operations is $3.51 billion, with the most recent change of -$270.88 million (-7.17%) on June 30, 2025.
  • Over the past year, AZN quarterly CFO has increased by +$311.12 million (+9.73%).
  • AZN quarterly CFO is now -13.26% below its all-time high of $4.05 billion, reached on December 31, 2009.

Performance

AZN quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAZNcash flow metrics

TTM CFO:

$13.72B+$311.12M(+2.32%)
June 30, 2025

Summary

  • As of today (August 21, 2025), AZN TTM cash flow from operations is $13.72 billion, with the most recent change of +$311.12 million (+2.32%) on June 30, 2025.
  • Over the past year, AZN TTM CFO has increased by +$2.29 billion (+20.06%).
  • AZN TTM CFO is now at all-time high.

Performance

AZN TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAZNcash flow metrics

Cash from operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

AZN Cash from operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+14.7%+9.7%+20.1%
3 y3 years+98.9%+179.6%+79.7%
5 y5 years+299.5%+234.5%+266.1%

AZN Cash from operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+98.9%-7.2%+179.6%at high+79.7%
5 y5-yearat high+299.5%-7.2%+292.1%at high+266.1%
alltimeall timeat high+5650.2%-13.3%+455.6%at high+2952.0%

AZN Cash from operations History

DateAnnualQuarterlyTTM
Jun 2025
-
$3.51B(-7.2%)
$13.72B(+2.3%)
Mar 2025
-
$3.78B(+27.3%)
$13.40B(+9.8%)
Dec 2024
$11.86B(+14.7%)
$2.97B(-14.1%)
$12.20B(+4.4%)
Sep 2024
-
$3.46B(+8.1%)
$11.69B(+2.4%)
Jun 2024
-
$3.20B(+24.0%)
$11.42B(+14.1%)
Mar 2024
-
$2.58B(+4.9%)
$10.01B(-5.8%)
Dec 2023
$10.35B(+5.5%)
$2.46B(-22.9%)
$10.63B(+0.3%)
Sep 2023
-
$3.19B(+78.6%)
$10.61B(+2.3%)
Jun 2023
-
$1.78B(-44.2%)
$10.36B(+5.4%)
Mar 2023
-
$3.20B(+31.6%)
$9.83B(-0.4%)
Dec 2022
$9.81B(+64.5%)
$2.43B(-17.4%)
$9.87B(+11.4%)
Sep 2022
-
$2.95B(+134.7%)
$8.86B(+16.1%)
Jun 2022
-
$1.25B(-61.2%)
$7.63B(+4.9%)
Mar 2022
-
$3.23B(+127.2%)
$7.27B(+21.3%)
Dec 2021
$5.96B(+24.3%)
$1.42B(-17.2%)
$6.00B(-5.9%)
Sep 2021
-
$1.72B(+92.2%)
$6.38B(-1.7%)
Jun 2021
-
$895.00M(-54.3%)
$6.48B(-2.3%)
Mar 2021
-
$1.96B(+8.7%)
$6.64B(+37.0%)
Dec 2020
$4.80B(+61.6%)
$1.80B(-1.4%)
$4.85B(+9.2%)
Sep 2020
-
$1.83B(+74.3%)
$4.44B(+18.4%)
Jun 2020
-
$1.05B(+528.1%)
$3.75B(+3.7%)
Mar 2020
-
$167.00M(-88.0%)
$3.61B(+16.7%)
Dec 2019
$2.97B(+13.4%)
$1.39B(+22.3%)
$3.09B(-22.0%)
Sep 2019
-
$1.14B(+24.5%)
$3.97B(+19.2%)
Jun 2019
-
$914.00M(-360.4%)
$3.33B(+29.6%)
Mar 2019
-
-$351.00M(-115.5%)
$2.57B(-8.7%)
Dec 2018
$2.62B(-26.8%)
$2.27B(+354.1%)
$2.81B(+77.0%)
Sep 2018
-
$499.00M(+226.1%)
$1.59B(-52.9%)
Jun 2018
-
$153.00M(-243.0%)
$3.38B(-3.6%)
Mar 2018
-
-$107.00M(-110.3%)
$3.50B(-6.4%)
Dec 2017
$3.58B(-13.7%)
$1.04B(-54.4%)
$3.74B(-20.3%)
Sep 2017
-
$2.29B(+716.4%)
$4.69B(+43.9%)
Jun 2017
-
$280.00M(+110.5%)
$3.26B(+2.5%)
Mar 2017
-
$133.00M(-93.3%)
$3.18B(-25.7%)
Dec 2016
$4.14B(+24.7%)
$2.00B(+133.9%)
$4.29B(+48.7%)
Sep 2016
-
$853.00M(+322.3%)
$2.88B(-24.5%)
Jun 2016
-
$202.00M(-83.6%)
$3.82B(-19.0%)
Mar 2016
-
$1.24B(+108.6%)
$4.71B(+36.8%)
Dec 2015
$3.32B(-52.9%)
$592.00M(-66.9%)
$3.45B(-27.4%)
Sep 2015
-
$1.79B(+62.7%)
$4.75B(-3.9%)
Jun 2015
-
$1.10B(-3534.4%)
$4.94B(-16.9%)
Mar 2015
-
-$32.00M(-101.7%)
$5.95B(-17.4%)
Dec 2014
$7.06B(-4.6%)
$1.89B(-4.3%)
$7.20B(-7.9%)
Sep 2014
-
$1.98B(-6.0%)
$7.82B(+11.6%)
Jun 2014
-
$2.11B(+73.1%)
$7.00B(+7.5%)
Mar 2014
-
$1.22B(-51.5%)
$6.51B(-12.9%)
Dec 2013
$7.40B(+6.5%)
$2.51B(+115.2%)
$7.48B(-5.1%)
Sep 2013
-
$1.17B(-27.9%)
$7.88B(-2.3%)
Jun 2013
-
$1.62B(-25.8%)
$8.06B(+4.2%)
Mar 2013
-
$2.18B(-25.1%)
$7.73B(+8.9%)
Dec 2012
$6.95B(-11.2%)
$2.91B(+115.8%)
$7.10B(-2.3%)
Sep 2012
-
$1.35B(+4.5%)
$7.27B(-7.5%)
Jun 2012
-
$1.29B(-16.6%)
$7.86B(+4.3%)
Mar 2012
-
$1.55B(-49.8%)
$7.53B(-5.6%)
Dec 2011
$7.82B
$3.08B(+59.0%)
$7.98B(-7.2%)
Sep 2011
-
$1.94B(+100.7%)
$8.60B(-6.0%)
DateAnnualQuarterlyTTM
Jun 2011
-
$965.08M(-51.7%)
$9.15B(-17.8%)
Mar 2011
-
$2.00B(-46.1%)
$11.14B(+2.5%)
Dec 2010
$10.68B(-9.0%)
$3.70B(+49.2%)
$10.87B(-3.0%)
Sep 2010
-
$2.48B(-15.8%)
$11.21B(+0.4%)
Jun 2010
-
$2.95B(+70.5%)
$11.16B(-0.9%)
Mar 2010
-
$1.73B(-57.2%)
$11.26B(-4.4%)
Dec 2009
$11.74B(+34.3%)
$4.05B(+66.1%)
$11.78B(+10.4%)
Sep 2009
-
$2.44B(-20.2%)
$10.67B(+7.7%)
Jun 2009
-
$3.05B(+35.8%)
$9.91B(+13.0%)
Mar 2009
-
$2.25B(-23.5%)
$8.77B(-2.2%)
Dec 2008
$8.74B(+16.4%)
$2.94B(+75.7%)
$8.97B(-1.4%)
Sep 2008
-
$1.67B(-12.7%)
$9.09B(+3.1%)
Jun 2008
-
$1.92B(-21.6%)
$8.82B(+10.1%)
Mar 2008
-
$2.44B(-20.2%)
$8.01B(+1.8%)
Dec 2007
$7.51B(-2.4%)
$3.06B(+118.3%)
$7.87B(+11.4%)
Sep 2007
-
$1.40B(+26.9%)
$7.06B(-10.6%)
Jun 2007
-
$1.10B(-52.0%)
$7.90B(-9.9%)
Mar 2007
-
$2.30B(+2.1%)
$8.77B(+9.1%)
Dec 2006
$7.69B(+14.1%)
$2.25B(+0.4%)
$8.04B(+3.2%)
Sep 2006
-
$2.24B(+13.5%)
$7.79B(+6.4%)
Jun 2006
-
$1.98B(+25.8%)
$7.32B(+4.9%)
Mar 2006
-
$1.57B(-21.4%)
$6.98B(+0.5%)
Dec 2005
$6.74B(+40.0%)
$2.00B(+12.7%)
$6.95B(-0.4%)
Sep 2005
-
$1.77B(+8.5%)
$6.97B(+11.2%)
Jun 2005
-
$1.63B(+6.2%)
$6.27B(+16.6%)
Mar 2005
-
$1.54B(-24.0%)
$5.38B(+8.8%)
Dec 2004
$4.82B(+43.0%)
$2.03B(+88.9%)
$4.94B(+19.0%)
Sep 2004
-
$1.07B(+44.8%)
$4.15B(+6.7%)
Jun 2004
-
$740.49M(-32.9%)
$3.89B(+8.1%)
Mar 2004
-
$1.10B(-10.8%)
$3.60B(+5.1%)
Dec 2003
$3.37B(-30.3%)
$1.24B(+52.6%)
$3.43B(-5.1%)
Sep 2003
-
$810.77M(+80.2%)
$3.61B(+1.7%)
Jun 2003
-
$450.00M(-51.5%)
$3.55B(-9.6%)
Mar 2003
-
$928.67M(-34.7%)
$3.93B(-18.9%)
Dec 2002
$4.83B(+54.6%)
$1.42B(+89.9%)
$4.84B(+19.3%)
Sep 2002
-
$748.83M(-9.6%)
$4.06B(-6.8%)
Jun 2002
-
$828.05M(-55.1%)
$4.36B(+16.5%)
Mar 2002
-
$1.84B(+188.2%)
$3.74B(+19.7%)
Dec 2001
$3.13B(+33.8%)
$640.08M(-38.6%)
$3.13B(+108.5%)
Sep 2001
-
$1.04B(+391.3%)
$1.50B(-39.2%)
Jun 2001
-
$212.27M(-82.8%)
$2.47B(-20.9%)
Mar 2001
-
$1.23B(-224.7%)
$3.12B(+33.4%)
Dec 2000
$2.34B(+9.9%)
-$986.91M(-149.1%)
$2.34B(-29.7%)
Sep 2000
-
$2.01B(+133.1%)
$3.32B(+153.2%)
Jun 2000
-
$862.75M(+92.0%)
$1.31B(+192.0%)
Mar 2000
-
$449.42M
$449.42M
Dec 1999
$2.13B(-37.9%)
-
-
Dec 1998
$3.42B(+358.0%)
-
-
Dec 1997
$747.21M(-5.1%)
-
-
Dec 1996
$787.75M(+34.5%)
-
-
Dec 1995
$585.64M(-6.4%)
-
-
Dec 1994
$625.36M(-11.4%)
-
-
Dec 1993
$705.58M(+242.1%)
-
-
Dec 1992
$206.27M(-59.2%)
-
-
Dec 1991
$505.22M(-37.3%)
-
-
Dec 1990
$806.30M
-
-

FAQ

  • What is AstraZeneca PLC annual cash flow from operations?
  • What is the all time high annual CFO for AstraZeneca PLC?
  • What is AstraZeneca PLC annual CFO year-on-year change?
  • What is AstraZeneca PLC quarterly cash flow from operations?
  • What is the all time high quarterly CFO for AstraZeneca PLC?
  • What is AstraZeneca PLC quarterly CFO year-on-year change?
  • What is AstraZeneca PLC TTM cash flow from operations?
  • What is the all time high TTM CFO for AstraZeneca PLC?
  • What is AstraZeneca PLC TTM CFO year-on-year change?

What is AstraZeneca PLC annual cash flow from operations?

The current annual CFO of AZN is $11.86B

What is the all time high annual CFO for AstraZeneca PLC?

AstraZeneca PLC all-time high annual cash flow from operations is $11.86B

What is AstraZeneca PLC annual CFO year-on-year change?

Over the past year, AZN annual cash flow from operations has changed by +$1.52B (+14.65%)

What is AstraZeneca PLC quarterly cash flow from operations?

The current quarterly CFO of AZN is $3.51B

What is the all time high quarterly CFO for AstraZeneca PLC?

AstraZeneca PLC all-time high quarterly cash flow from operations is $4.05B

What is AstraZeneca PLC quarterly CFO year-on-year change?

Over the past year, AZN quarterly cash flow from operations has changed by +$311.12M (+9.73%)

What is AstraZeneca PLC TTM cash flow from operations?

The current TTM CFO of AZN is $13.72B

What is the all time high TTM CFO for AstraZeneca PLC?

AstraZeneca PLC all-time high TTM cash flow from operations is $13.72B

What is AstraZeneca PLC TTM CFO year-on-year change?

Over the past year, AZN TTM cash flow from operations has changed by +$2.29B (+20.06%)
On this page